CHENGDA PHARMA
30120127.742.44% ( +0.66 )
Q1 2026 Earnings
Financial report interval: 2025.12.31 - 2026.03.31
Overview: CHENGDA PHARMA(301201) the Revenue is 128.24 M (+68.06%);the EBIT is 5.275 M (+194.3%);the EPS is 0.0462 (+602.2%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
Revenue
0.13B68.06%
----
----
EBIT
0.01B194.25%
----
----
EPS
0.0462602.17%
----
----
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf